Promise offers innovative solutions in the fields of therapeutic proteins, biomarkers, and quality controls. Their Stable Isotopically Labelled proteins (SIL-proteins) are considered the gold standard for protein quantification, ensuring the highest levels of accuracy. With their expertise in mass spectrometry-based quantification methods, Promise helps customers develop customized solutions for projects such as biomarker evaluation, pharmacokinetics studies, and stability studies of proteins. They have also developed mAbXmise kits, which are in vitro diagnostic medical devices used to monitor therapeutic antibodies prescribed for inflammatory diseases and cancer treatment.